Table 1.
Demographic and clinical characteristics of stroke admissions in Aragón before (pre‐CoV) and after (p‐CoV) the setting of the state of emergency in Spain
| pre‐CoV (n = 275) | p‐CoV (n = 79) | P | |
|---|---|---|---|
| Age, median (IQR) | 80 (68.0–86.0) | 78 (67.0–85.0) | 0.298 |
| >80 years, n (%) | 130 (47.3) | 32 (40.5) | 0.287 |
| Male, n (%) | 143 (52.0) | 42 (53.2) | 0.855 |
| In‐hospital stroke, n (%) | 15 (5.5) | 5 (6.3) | 0.783 |
| Strokes per week, median (IQR) | 27.5 (22.5–33.5) | 12 (10.8–16) | <0.001 |
| TP per week, median (IQR)a | 8.5 (6.3–9.3) | 4 (2.5–5.3) | 0.011 |
| IVT, n (%) | 58 (21.1) | 17 (21.5) | 0.935 |
| EVT, n (%) | 34 (12.4) | 12 (15.2) | 0.510 |
| >24 h from SO, n (%) | 59 (21.5) | 10 (12.7) | 0.082 |
| Unknown‐onset stroke, n (%) | 129 (46.9) | 35 (44.3) | 0.682 |
| ODT, min, median (IQR)b | 102 (65.3–196.8) | 183 (80.0–532.0) | 0.015 |
| mRS > 2, n (%) | 39 (14.2) | 15 (19.0) | 0.295 |
| Patients from retirement homes, n (%) | 18 (6.5) | 4 (5.1) | 0.794 |
| Brought in ambulance | 90 (32.7) | 32 (40.5) | 0.200 |
| ASPECTS, median (IQR)c | 10 (9–10) | 10 (9–10) | 0.309 |
| ASPECTS < 6, n (%)c | 9 (4.0) | 4 (5.9) | 0.508 |
| NIHSS, median (IQR) | 5 (2–11) | 6 (3–12) | 0.156 |
| NIHSS < 5, n (%) | 143 (52.0) | 38 (48.1) | 0.541 |
| NIHSS > 15, n (%) | 39 (14.2) | 13 (16.5) | 0.615 |
| DNT, min, median (IQR) | 50 (35.0–70.3) | 64 (38.5–89.0) | 0.112 |
| DPT, min, median (IQR) | 59.5 (37.3–108.5) | 68 (41.8–126.8) | 0.388 |
ASPECTS, Alberta Stroke Program Early Computed Tomography Score; DNT, door‐to‐needle time; DPT, door‐to‐puncture time; EVT, endovascular therapy; IQR, interquartile range; IVT, intravenous thrombolysis; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; ODT, onset‐to‐door time; SO, symptom onset; TP, treated patients. Bold font indicates statistical significance.
aTreated patients are the ones who received IVT and/or EVT; bout‐of‐hospital patients with less than 24 h from symptom onset; conly patients with anterior circulation strokes.